Ondřej Zapletal

Dabigatran etexilate for the treatment of acute venous thromboembolism in children (DIVERSITY): a randomised, controlled, open-label, phase 2b/3, non-inferiority trial

Leonardo R. Brandão, Matteo Luciani, Lisa Bomgaars et al. · The Lancet Haematology · 2020 · 134 citations · Full text

Thrombosis, Venous Disease, Venous Thrombosis +8

Safety of dabigatran etexilate for the secondary prevention of venous thromboembolism in children

Leonardo R. Brandão, Manuela Albisetti, Lisa Bomgaars et al. · Blood · 2019 · 90 citations · Full text

Loss of B cells and their precursors is the most constant feature of GATA-2 deficiency in childhood myelodysplastic syndrome

Michaela Nováková, Markéta ŽAliová, Martina Suková et al. · Haematologica · 2016 · 67 citations · Full text

Mixed-phenotype Acute Leukemia, Genetics, Immunology +18

CEBPE-Mutant Specific Granule Deficiency Correlates With Aberrant Granule Organization and Substantial Proteome Alterations in Neutrophils

Nina K. Serwas, Jakob Huemer, Régis Dieckmann et al. · Frontiers in Immunology · 2018 · 36 citations · Full text

A comparative analysis of different automated von Willebrand factor glycoprotein Ib‐binding activity assays in well typed von Willebrand disease patients

Inge Vangenechten, Katarzina Mayger, Petr Šmejkal et al. · Journal of Thrombosis and Haemostasis · 2018 · 35 citations · Full text

Autoimmune Disease, Medicine, Hematology +3